Literature DB >> 22282255

Caspase-3 mediates apoptosis of striatal cells in GA I rat model.

Fengyan Tian1, Xi Fu1, Jinzhi Gao1, Cai Zhang1, Qin Ning2, Xiaoping Luo3.   

Abstract

In previous study, glutaric acid (GA) induced apoptosis of primary striatal neuron in vitro. In order to investigate the neurotoxic effects of GA on neonatal rat corpus striatum and the possible mechanism, 34 male pups were randomly assigned to NS group, low dose GA (LGA, 5 μmol GA/g body weight) group and high dose GA (HGA, 10 μmol GA/g body weight) group. These pups were subcutaneously administered with three injections from postnatal day 3 to 22 at 7:30 am, 15:00 pm and 22:30 pm and killed 12 h after the last injection. Microscopic pathology in corpus striatum was evaluated by HE staining. The apoptotic cells were identified by TUNEL staining. The transcript levels of caspase-3, 8, 9, Bax, Bcl-2 were detected by using real-time PCR and the protein levels of procaspase-3 and the active fraction were evaluated by Western blotting. In LGA and HGA groups, ventricle collapse, cortical atrophy by a macroscope and interstitial edema, vacuolations, widened perivascular space of bilateral striatum by a microscope were observed. TUNEL assay revealed that the apoptotic cells were increased in LGA and HGA groups. The transcript of caspase-3 was up-regulated to 2.5 fold, accompanied by the up-regulation of caspase-9, Bax and down-regulation of Bcl-2. The protein levels of procaspase-3 and the active fraction were up-regulated in LGA and HGA groups. The rat model for GA I showed mitochondrial apoptotic pathway may be involved in the GA-induced striatal lesion. Further studies should be taken to investigate the underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282255     DOI: 10.1007/s11596-012-0019-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  18 in total

1.  Glutaric acid administration impairs energy metabolism in midbrain and skeletal muscle of young rats.

Authors:  Gustavo da C Ferreira; Carolina M Viegas; Patrícia F Schuck; Anelise Tonin; César A J Ribeiro; Daniella de M Coelho; Teresa Dalla-Costa; Alexandra Latini; Angela T S Wyse; Clovis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

2.  Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency.

Authors:  Sven W Sauer; Jürgen G Okun; Gert Fricker; Anne Mahringer; Ines Müller; Linda R Crnic; Chris Mühlhausen; Georg F Hoffmann; Friederike Hörster; Stephen I Goodman; Cary O Harding; David M Koeller; Stefan Kölker
Journal:  J Neurochem       Date:  2006-03-29       Impact factor: 5.372

Review 3.  Glutaric aciduria type I and kynurenine pathway metabolites: a modified hypothesis.

Authors:  S Varadkar; R Surtees
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I.

Authors:  David M Koeller; Michael Woontner; Linda S Crnic; Bette Kleinschmidt-DeMasters; Janet Stephens; Edgar L Hunt; Stephen I Goodman
Journal:  Hum Mol Genet       Date:  2002-02-15       Impact factor: 6.150

5.  Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood-brain barrier and the choroid plexus.

Authors:  Sven W Sauer; Silvana Opp; Anne Mahringer; Marcin M Kamiński; Christian Thiel; Jürgen G Okun; Gert Fricker; Marina A Morath; Stefan Kölker
Journal:  Biochim Biophys Acta       Date:  2010-03-17

6.  Transport and distribution of 3-hydroxyglutaric acid before and during induced encephalopathic crises in a mouse model of glutaric aciduria type 1.

Authors:  Britta Keyser; Markus Glatzel; Franziska Stellmer; Bastian Kortmann; Zoltan Lukacs; Stefan Kölker; Sven W Sauer; Nicole Muschol; Wilhelm Herdering; Joachim Thiem; Stephen I Goodman; David M Koeller; Kurt Ullrich; Thomas Braulke; Chris Mühlhausen
Journal:  Biochim Biophys Acta       Date:  2008-02-29

7.  Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.

Authors:  G F Hoffmann; S Athanassopoulos; A B Burlina; M Duran; J B de Klerk; W Lehnert; J V Leonard; A A Monavari; E Müller; A C Muntau; E R Naughten; B Plecko-Starting; A Superti-Furga; J Zschocke; E Christensen
Journal:  Neuropediatrics       Date:  1996-06       Impact factor: 1.947

8.  Chronic early postnatal glutaric acid administration causes cognitive deficits in the water maze.

Authors:  Gustavo da Costa Ferreira; Patrícia Fernanda Schuck; Carolina Maso Viegas; Anelise Tonin; César Augusto João Ribeiro; Leticia Ferreira Pettenuzzo; Lenir Orlandi Pereira; Carlos Alexandre Netto; Moacir Wajner
Journal:  Behav Brain Res       Date:  2007-10-11       Impact factor: 3.332

9.  [Macrocephaly as the initial manifestation of glutaryl-CoA-dehydrogenase deficiency (glutaric aciduria type I)].

Authors:  F K Trefz; G F Hoffmann; E Mayatepek; U Lichter-Konecki; J Weisser; A Otten; U Wendel; D Rating; H J Bremer
Journal:  Monatsschr Kinderheilkd       Date:  1991-11       Impact factor: 0.323

10.  New insights and new issues in developmental neurotoxicology.

Authors:  John W Olney
Journal:  Neurotoxicology       Date:  2002-12       Impact factor: 4.294

View more
  2 in total

1.  Effects of targeted suppression of glutaryl-CoA dehydrogenase by lentivirus-mediated shRNA and excessive intake of lysine on apoptosis in rat striatal neurons.

Authors:  Jinzhi Gao; Cai Zhang; Xi Fu; Qin Yi; Fengyan Tian; Qin Ning; Xiaoping Luo
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

2.  Correlation of expression levels of caspase-3 and Bcl-2 in alveolar lavage fluid in neonatal respiratory distress syndrome and prognosis.

Authors:  Yongmei Li; Lu Lin; Qingxi Wang
Journal:  Exp Ther Med       Date:  2018-01-16       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.